Fitch Affirms Glenmark Pharmaceuticals at ‘BB’ on IPO of API Business; Outlook Stable

Fitch Ratings has affirmed India-based Glenmark Pharmaceuticals Ltd’s Long-Term Issuer Default Rating (IDR) at ‘BB’ after its active pharmaceutical ingredient (API) business completed an IPO. The …
( read original story …)


Search your Hotel